LMT vs PLSE · P/E 20, rev $20.06B vs rev $835.0K
Lockheed Martin Corporation (LMT) versus Pulse Biosciences Inc (PLSE) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Pulse Biosciences Inc (PLSE) is a medical instruments & supplies company listed on US.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported PLSE revenue for 2026-06-30 was $835.0K. Net income was -$43.2M. PLSE currently screens at market cap $1.03B.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. PLSE currently screens at market cap $1.03B.
Not investment advice. Open the LMT and PLSE stock pages for the full models.
Not investment advice.